22CM
TEVA icon

20/20 Capital Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

20/20 Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-34
Closed – – 175
2020
Q3 		$0 Hold
34
– – ﹤0.01% 158
2020
Q2 		$0 Hold
34
– – ﹤0.01% 157
2020
Q1 		$0 Buy
+34
New +$348 ﹤0.01% 153

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Abrams Capital Management
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

20/20 Capital Management's TEVA Position: Q4 2020 in Review

20/20 Capital Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2020, closing a stake of 34 shares.

20/20 Capital Management first reported a position in TEVA in Q1 2020 and held it in 3 quarters. The position peaked at $0 in Q3 2020. 450 funds tracked by Wall St. Rank hold TEVA as of Q4 2020.

  • 20/20 Capital Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2020 after selling out during the quarter.
  • 20/20 Capital Management sold 34 Teva Pharmaceutical Industries Limited shares in Q4 2020.
  • 20/20 Capital Management first reported a position in Teva Pharmaceutical Industries Limited in Q1 2020 and held it in 3 quarters.
  • 20/20 Capital Management's Teva Pharmaceutical Industries Limited position peaked at $0 in Q3 2020.
  • 450 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2020.

Based on 20/20 Capital Management's 13F filing for Q4 2020, filed 3 Feb 2021.